Coe Mary Ellen — SEC insider filings
SEC reporting owner CIK 1691304. 31 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2020-10-02 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | Director | 31 | — | — | 31 |
Insider filings — Coe Mary Ellen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 206.46 (derivative) @ $145.31 | EDGAR |
| 2026-07-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 233.46 (derivative) @ $128.50 | EDGAR |
| 2026-06-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 1,853.10 (derivative) @ $118.72 | EDGAR |
| 2026-04-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 249.40 (derivative) @ $120.29 | EDGAR |
| 2026-01-05 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 285.01 (derivative) @ $105.26 | EDGAR |
| 2025-10-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 357.44 (derivative) @ $83.93 | EDGAR |
| 2025-07-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 378.98 (derivative) @ $79.16 | EDGAR |
| 2025-06-03 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 2,863.09 (derivative) @ $76.84 | EDGAR |
| 2025-04-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 334.22 (derivative) @ $89.76 | EDGAR |
| 2025-01-03 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 301.57 (derivative) @ $99.48 | EDGAR |
| 2024-10-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 264.18 (derivative) @ $113.56 | EDGAR |
| 2024-07-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 242.33 (derivative) @ $123.80 | EDGAR |
| 2024-06-04 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 1,752.43 (derivative) @ $125.54 | EDGAR |
| 2024-03-29 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 227.36 (derivative) @ $131.95 | EDGAR |
| 2024-01-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 275.18 (derivative) @ $109.02 | EDGAR |
| 2023-10-03 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 291.40 (derivative) @ $102.95 | EDGAR |
| 2023-07-05 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 259.99 (derivative) @ $115.39 | EDGAR |
| 2023-05-31 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 1,980.73 (derivative) @ $111.07 | EDGAR |
| 2023-04-03 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 304.17 (derivative) @ $106.39 | EDGAR |
| 2023-01-03 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 292.92 (derivative) @ $110.95 | EDGAR |
| 2022-10-04 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 377.38 (derivative) @ $86.12 | EDGAR |
| 2022-07-05 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 356.48 (derivative) @ $91.17 | EDGAR |
| 2022-06-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 2,363.56 (derivative) @ $93.08 | EDGAR |
| 2022-04-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 396.10 (derivative) @ $82.05 | EDGAR |
| 2022-01-04 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 424.06 (derivative) @ $76.64 | EDGAR |
| 2021-10-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 432.70 (derivative) @ $75.11 | EDGAR |
| 2021-07-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 417.90 (derivative) @ $77.77 | EDGAR |
| 2021-06-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 2,635.39 (derivative) @ $75.89 | EDGAR |
| 2021-04-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 421.59 (derivative) @ $77.09 | EDGAR |
| 2021-01-05 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 397.31 (derivative) @ $81.80 | EDGAR |
| 2020-10-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 391.80 (derivative) @ $82.95 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1691304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs